PGHH Appoints Srividya Srinivasan as CFO; Hegde & Bhartia Resign
PGHH Board approved leadership changes on May 28, 2026. Ghanashyam Hegde resigns as Company Secretary/Compliance Officer (June 30, 2026) and becomes Non-Executive Director (July 1, 2026). Gaurav Bhartia resigns as CFO (June 30, 2026). Srividya Srinivasan appointed Executive Director & CFO from July 1, 2026.
Key management changes, especially the CFO role, can have a medium-term impact on company strategy and operations.
The announcement details routine management changes and appointments, with no immediate positive or negative financial implications mentioned.
Procter & Gamble Hygiene and Health Care Limited announced significant changes in its leadership team, approved by the Board of Directors on May 28, 2026.
Mr. Ghanashyam Hegde will cease to be Company Secretary and Compliance Officer effective June 30, 2026, as he moves to a regional role within P&G. He will be re-designated as a Non-Executive Director from July 1, 2026. Mr. Hegde's new role will be Vice President & Associate General Counsel – Market Operations, India, Middle East, Turkey & Africa.
Mr. Gaurav Bhartia will also step down as Chief Financial Officer on June 30, 2026, to take up a new assignment at P&G.
Ms. Srividya Srinivasan has been appointed as the new Executive Director and Chief Financial Officer, effective July 1, 2026. Her appointment is for a period of five years, subject to Board approval at the upcoming 62nd Annual General Meeting. Ms. Srinivasan holds a Bachelor of Computer Science Engineering and an MBA in Finance, with 20 years of experience at P&G across various finance roles and markets.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.